Search results for "Graine"

showing 10 items of 294 documents

Social distancing in chronic migraine during the covid-19 outbreak: Results from a multicenter observational study

2021

Background: The restrictions taken to control the rapid spread of COVID-19 resulted in a sudden, unprecedented change in people’s lifestyle, leading to negative consequences on general health. This study aimed to estimate the impact of such changes on migraine severity during 2020 March–May lockdown. Methods: Patients affected by migraine with or without aura, diagnosed by expert physicians, completed a detailed interview comprehensive of: assessment of migraine characteristics

AdultSleep Wake Disordersmedicine.medical_specialtyAuraMigraine DisordersPhysical DistancingMetabolic equivalentArticle03 medical and health sciences0302 clinical medicineChronic MigraineQuality of lifeInternal medicineSurveys and QuestionnairesEpidemiologymedicineHumansTX341-641030212 general & internal medicineExerciseLife StyleMigraineNutritionSleep disorderSleep disorderNutrition and DieteticsCOVID-19; Migraine; Nutrition; Physical activity; Quarantine; Sleep disorder; Adult; COVID-19; Communicable Disease Control; Exercise; Feeding Behavior; Headache; Humans; Italy; Life Style; Middle Aged; Migraine Disorders; Quality of Life; Quarantine; SARS-CoV-2; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Physical Distancingbusiness.industryNutrition. Foods and food supplyPhysical activitySARS-CoV-2HeadacheCOVID-19Feeding BehaviorMiddle Agedmedicine.diseaseMigraineItalyQuarantineCommunicable Disease ControlQuality of LifeObservational studySettore MED/26 - Neurologiasense organsbusinessSleep030217 neurology & neurosurgeryFood Science
researchProduct

Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, …

2012

The objective of the study was to compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (IHS Classification of Headache disorders) enrolled in a multicenter, randomized, double-blind, cross-over study. Patients received frovatriptan 2.5 mg or almotriptan 12.5 mg in a randomized sequence: after treating 3 episodes of migraine in no more than 3 months with the first treatment, the patient was switched to the other treatment. 67 of the 96 female patients of the intention-to-treat population of the main study had regular menstrual cycles and were thus included in this subgroup analysis. 77 migraine attacks classified as related to menses were…

AdultTime FactorsOriginalMigraine DisordersPopulationAlmotriptanClinical NeurologyCarbazolesSubgroup analysisSeverity of Illness IndexAdult; Carbazoles; Cross-Over Studies; Disability Evaluation; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Proportional Hazards Models; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; TryptaminesDisability EvaluationDouble-Blind MethodAlmotriptanSeverity of illnessMedicineHumanseducationMigraine Menstrually related migraine Frovatriptan AlmotriptanMenstrually related migraineMenstruation DisturbancesMigraineMenstrually related migraineProportional Hazards Modelseducation.field_of_studyCross-Over Studiesbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseCrossover studyTryptaminesSerotonin Receptor Agonistsfrovatriptan; migraine; menstrually related migraine; almotriptanAnesthesiology and Pain MedicineTreatment OutcomeMigraineItalyAnesthesiaFemaleNeurology (clinical)businessFrovatriptanFrovatriptanmedicine.drug
researchProduct

Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled Trials

2008

Objective.  Topiramate is an effective and generally well-tolerated migraine preventive therapy, as shown in three large, randomized, double-blind, placebo-controlled registration trials. Based upon efficacy/tolerability, topiramate 100 mg/day (50 mg BID) is the recommended target dose for most patients with migraine. To further assess the safety and tolerability of topiramate for migraine prevention, we analyzed safety data from 1,580 patients who participated in the three pivotal registration trials or an earlier pilot, randomized, double-blind, placebo-controlled trial. Methods.  The safety population consisted of all patients who took ≥1 dose of study medication during the double-blind …

AdultTopiramateAdolescentNauseaMigraine DisordersPopulationPhysical examinationFructosePlaceboTopiramatemedicineHumansChildAdverse effecteducationAgedRandomized Controlled Trials as Topiceducation.field_of_studymedicine.diagnostic_testbusiness.industryPatient SelectionDrug ToleranceGeneral MedicineMiddle Agedmedicine.diseaseNeuroprotective AgentsAnesthesiology and Pain MedicineTolerabilityMigraineAnesthesiaNeurology (clinical)Safetymedicine.symptombusinessmedicine.drugPain Medicine
researchProduct

Migraine and handedness.

2020

Migraine is a typically unilateral disorder in adulthood; however, the reasons for painful lateralization have been little investigated. The possible influence of manual dominance was suggested. We aimed to investigate the localization of pain in migraine attacks in right-handed and left-handed subjects. The retrospective study collected 546 patients with migraine aged between 16 and 65 years, reporting the manual dominance to the Edinburgh test. We included 466 right-handed and 80 left-handed subjects with migraine. We registered 4215 unilateral painful attacks. The right-handers had 3412 unilateral episodes; 62.8% of the attacks were characterized by pain on the right side and 37.2% by pa…

Adultmedicine.medical_specialtyNeurologyAdolescentMigraine DisordersPainDermatologyManual dominanceAudiologyLateralization of brain functionFunctional Laterality03 medical and health sciencesYoung AdultRight-handers0302 clinical medicineLeft-handersmedicineHumans030212 general & internal medicineUnilateral painHandednessMigraineNeuroradiologyAgedRetrospective Studiesbusiness.industryRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseHandPsychiatry and Mental healthManual dominanceMigraineNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryPsychomotor PerformanceNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG study.

2021

International audience; Background and purpose The efficacy of patent foramen ovale (PFO) closure to reduce the frequency of migraine attacks remains controversial. Methods This was a planned sub-study in migraine patients enrolled in a randomized, clinical trial designed to assess the superiority of PFO closure plus antiplatelet therapy over antiplatelet therapy alone to prevent stroke recurrence in patients younger than 60 years with a PFO-associated cryptogenic ischaemic stroke. The main outcome was the mean annual number of migraine attacks in migraine patients with aura and in those without aura, as recorded at each follow-up visit by study neurologists. Results Of 473 patients randomi…

Adultmedicine.medical_specialtyStroke patientAuraSeptal Occluder Device[SDV]Life Sciences [q-bio]Migraine DisordersForamen Ovale PatentBrain Ischemia03 medical and health sciences0302 clinical medicineInternal medicineIschaemic strokemedicineHumans030212 general & internal medicineClosure (psychology)Foramen ovale (heart)business.industryMiddle Agedmedicine.diseaseClinical trialStrokemedicine.anatomical_structureTreatment OutcomeNeurologyMigraineCardiologyPatent foramen ovaleFemaleNeurology (clinical)business030217 neurology & neurosurgeryPlatelet Aggregation InhibitorsEuropean journal of neurologyREFERENCES
researchProduct

The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations

2022

AgingMigraine DisordersHumansmigraineSettore MED/26 - NeurologiaGeriatrics and Gerontologydementia
researchProduct

Modulation of visual cortex excitability in migraine with aura: effects of valproate therapy.

2009

We explored the effects of valproate treatment on visual cortex excitability changes in migraine with aura patients. Abnormal cortical excitability has been suggested to play an important role in the etiopathogenesis of migraine; in particular, it has been suggested a failure of inhibitory circuits in migraine with aura. Valproate acts as a central GABA agonist and it is reasonable suppose that VPA could modify cortical excitability state. Phosphene threshold (PT) was assessed at baseline and after 1 Hz rTMS before and after one month therapy. We found that low-frequency rTMS in drug-free migraineurs decreased PT, while the treatment with the GABA agonist valproate is able to revert the eff…

AgonistAdultMaleTime Factorsmedicine.drug_classGABA Agentsmedicine.medical_treatmentMigraine with AuraPhosphenesSettore BIO/09 - FisiologiaYoung AdultCortex (anatomy)medicineHumansvisual cortex excitability migraine with auraVisual CortexValproic AcidAnalysis of VarianceGeneral NeuroscienceValproic AcidMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationMigraine with auraAnticonvulsantVisual cortexmedicine.anatomical_structurePhosphenenervous systemMigraineSettore MED/26 - NeurologiaFemalemedicine.symptomPsychologyNeurosciencemedicine.drugNeuroscience letters
researchProduct

Alexithymic characteristics in pediatric patients with primary headache: a comparison between migraine and tension-type headache

2015

Background: Alexithymia is a personality construct characterized by difficulties in verbal emotional expression and a limited ability to use one’s imagination. Evidence of alexithymic characteristics was found in adults suffering from headache, while little is known about children. The aim of this study was to establish the prevalence of alexithymia in two different subgroups of children and adolescents suffering from primary headache. We also looked for correlation between alexithymia in children and in their mothers. Methods: This study involved 89 participants: 47 (11 males, 36 females, aged 8 to 17 years) suffering from tension-type headache (TTH), and 42 (18 males, 24 females, aged 8 t…

AlexithymiaMaleAlexithymia; Alexithymia Questionnaire for Children; Migraine; Tension-type headache; Toronto Alexithymia ScaleToronto Alexithymia ScaleAlexithymiaMigraine DisorderSurveys and QuestionnairesPrevalenceSurveys and QuestionnaireEmotional expressionChildmedia_commonMothermedicine.diagnostic_testAlexithymia; Alexithymia Questionnaire for Children; Migraine; Tension-type headache; Toronto Alexithymia Scale; Adolescent; Analysis of Variance; Case-Control Studies; Child; Female; Humans; Male; Migraine Disorders; Mood Disorders; Mothers; Prevalence; Surveys and Questionnaires; Tension-Type Headache; Anesthesiology and Pain Medicine; Neurology (clinical)General MedicineSettore MED/39 - Neuropsichiatria InfantileFemaleHeadachesmedicine.symptomCase-Control StudieResearch ArticleClinical psychologyHumanmedicine.medical_specialtyMood DisorderAdolescentMigraine Disordersmedia_common.quotation_subjectClinical NeurologyMothersmedicineHumansPersonalityPsychiatryMigraineAnalysis of VarianceMood Disordersbusiness.industryAlexithymia Questionnaire for ChildrenTension-Type Headachemedicine.diseaseAnesthesiology and Pain MedicineMigraineMood disordersCase-Control StudiesToronto Alexithymia ScaleInternational Classification of Headache DisordersNeurology (clinical)businessThe Journal of Headache and Pain
researchProduct

Brain excitability in migraine: Hyperexcitability or inhibited inhibition?

2007

While migraine has been considered for a long time a disease of the head vascular structures, it has been more and more evident that the involvement of the cerebral cortex has a primary role in the cascade of events which trigger the migraine attacks. Neurophysiological studies gave an important contribution to our knowledge of the mechanisms underlying the migraine disease

Anesthesiology and Pain Medicinemigraine disordersNeurologyMigrainebusiness.industryMedicineNeurology (clinical)Pharmacologybusinessmedicine.diseasePain
researchProduct

Impaired Glutamatergic Neurotransmission in Migraine With Aura? Evidence by an Input-Output Curves Transcranial Magnetic Stimulation Study

2011

(Headache 2011;51:726-733) Objective.— An imbalance between activity of inhibitory and facilitatory intracortical circuits could play a central role in migraine etiology. We used input–output curves to achieve further information about intracortical excitability of motor cortex in migraine with aura. Methods.— Input–output curves were measured in the right abductor pollicis brevis muscle at rest in 12 patients suffering from migraine with aura and 8 healthy subjects. Stimuli were delivered at intensity ranging from 100% to 160% of resting motor threshold with 10-second inter-stimulus intervals. Seven patients were studied before and during treatment with levetiracetam. Results.— Results sho…

Auramedicine.medical_treatmentNeurological disordermedicine.diseaseMigraine with auraTranscranial magnetic stimulationmedicine.anatomical_structureNeurologyMigraineAnesthesiamedicineIctalNeurology (clinical)Levetiracetammedicine.symptomPsychologyMotor cortexmedicine.drugHeadache: The Journal of Head and Face Pain
researchProduct